Have had a read - will re-read later - frankly, not a bad result. PhII trials are learning trials and they may choose to tweak some things, but overall a pretty solid result. I think, if I've read it correctly, where things got a bit "weird' was the USA delivered an unexpected result from the "control group" which may have muddied the waters a little, but that's not a normal, so statistically I wouldn't take it to the bank. Others more medically minded will clarify, but certainly no major negative there.
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-141
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |